Summary
Elevance Health, Inc. (ELV), formerly WellPoint, Inc., issued this Form 8-K filing on March 14, 2011, to disclose information that would be shared with securities analysts and investors during meetings scheduled from March 15 to March 31, 2011. The primary purpose of the filing was to reaffirm the company's full-year 2011 earnings per share (EPS) guidance. Specifically, WellPoint confirmed its expectation to achieve an EPS of at least $6.30 for the fiscal year 2011. This reaffirms the company's financial outlook and provides clarity to the investment community regarding its performance expectations. The filing also includes a standard safe harbor statement, reminding investors that forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially from those projected.
Key Highlights
- 1Reaffirmed full-year 2011 earnings per share (EPS) guidance of at least $6.30.
- 2Information was shared with securities analysts and investors during meetings from March 15-31, 2011.
- 3The filing serves as a Regulation FD disclosure.
- 4Company name at the time was WellPoint, Inc.
- 5Includes standard safe harbor statement for forward-looking statements.
- 6Potential risks and uncertainties affecting future performance were noted, including regulatory impacts from the Patient Protection and Affordable Care Act.